Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Pain trade or same trade? Investors refuse to fold on recession bets By Reuters
© Reuters. Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 6, 2023. REUTERS/Brendan McDermid By
Manhattan office market’s tough outlook persists, leaving investors on sidelines By Reuters
2/2 © Reuters. FILE PHOTO: The Empire State Building and Manhattan skyline are pictured from the Summit at One Vanderbilt observatory in Manhattan in New
Analysis-US stock investors count on earnings to propel rally after upbeat CPI report By Reuters
© Reuters. Options floor brokers work on the floor of the NYSE American, formerly known as the American Stock Exchange (AMEX), at New York Stock
Domino's Investors Overpay for a Pizza the Action
The pizza chain’s Uber deal is an acknowledgment that Domino’s could no longer go it alone. Investors should applaud its flexibility, but not quite so
ESMA warns of risks arising from securities lending to retail investors
The European Securities and Markets Authority (ESMA), the EU’s financial markets regulator and supervisor, today published a Statement on securities lending to retail clients. Certain
Investors target consumer goods makers on fears of customer exodus over high prices By Reuters
© Reuters. People shop in a supermarket as inflation affected consumer prices in Manhattan, New York City, U.S., June 10, 2022. REUTERS/Andrew Kelly By Richa
Analysis-Global investors relieved by China tech rebound, but not convinced yet By Reuters
2/2 © Reuters. FILE PHOTO-Alibaba Group sign is seen at the World Artificial Intelligence Conference (WAIC) in Shanghai, China July 6, 2023. REUTERS/Aly Song 2/2
U.S. stocks are rising as investors await inflation report By Investing.com
© Reuters. Investing.com — U.S. stocks are rising in early trading as investors anticipate the release of June’s consumer price index on Wednesday. At 9:32
FDA's OK Isn't Always a Happy Day for Biotech Investors
In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link